Sparstolonin B nano-formulation attenuates LPS-induced lung injury
IntroductionNanomedicines can improve drug delivery and efficacy while reducing side effects. Our study examines the impact of a nano-formulation of Sparstolonin B (nSsnB), a TLR-4 antagonist, on LPS-induced inflammation in RAW264.7 cells and lung injury in mice.MethodsRAW264.7 cells were treated wi...
Saved in:
| Main Authors: | Qinghe Meng, Xiaojing Wang, Dandan Guo, Gary Zhang, Changying Shi, Adam Novak, Xiguang Yang, Juntao Luo, Robert N. Cooney |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1532391/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determining the Bordetella LPS structural features that influence TLR4 downstream signaling
by: Kiruthika Manivannan, et al.
Published: (2025-02-01) -
Enhancing autophagy mitigates LPS-induced neuroinflammation by inhibiting microglial M1 polarization and neuronophagocytosis
by: Jingjing Guo, et al.
Published: (2025-02-01) -
Sparstolonin B Suppresses Proliferation and Modulates Toll-like Receptor Signaling and Inflammatory Pathways in Human Colorectal Cancer Cells
by: Bürke Çırçırlı, et al.
Published: (2025-02-01) -
Gamma -aminobutyric acid ameliorates neurological impairments in type 1 diabetes mellitus mice by regulating the “gut flora-LPS-TLR4-NF-ΚB” signalling Axis
by: Jiao Wang, et al.
Published: (2025-05-01) -
Sparstolonin B Reduces Estrogen-Dependent Proliferation in Cancer Cells: Possible Role of Ceramide and PI3K/AKT/mTOR Inhibition
by: Yağmur Dilber, et al.
Published: (2024-11-01)